Terms: = Cervical cancer AND PR, PGR, progesterone receptor AND Clinical Outcome
9 results:
1. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract] [Full Text] [Related]
3. Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
Xu Y; Zhu L; Liu B; Ru T; Wang H; He J; Liu S; Yang X; Zhou Z; Liu T
BMC Cancer; 2017 Jun; 17(1):427. PubMed ID: 28629386
[TBL] [Abstract] [Full Text] [Related]
4. Three-dimensional power Doppler ultrasound in the early assessment of response to concurrent chemo-radiotherapy for advanced cervical cancer.
Xu Y; Zhu L; Ru T; Wang H; He J; Zhou Z; Yang X
Acta Radiol; 2017 Sep; 58(9):1147-1154. PubMed ID: 28068824
[TBL] [Abstract] [Full Text] [Related]
5. clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature.
Blake EA; Sheridan TB; Wang KL; Takiuchi T; Kodama M; Sawada K; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():163-70. PubMed ID: 25150955
[TBL] [Abstract] [Full Text] [Related]
6. Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein.
Kuroda H; Toyozumi Y; Masuda T; Ougida T; Hanami K; Kyoko K; Tamaru J; Itoyama S
Acta Cytol; 2006; 50(4):418-22. PubMed ID: 16901007
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer.
Schoppmann SF; Schindl M; Bayer G; Aumayr K; Dienes J; Horvat R; Rudas M; Gnant M; Jakesz R; Birner P
Int J Cancer; 2003 May; 104(6):677-82. PubMed ID: 12640673
[TBL] [Abstract] [Full Text] [Related]
9. progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix.
Suzuki Y; Nakano T; Arai T; Morita S; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1229-34. PubMed ID: 10889376
[TBL] [Abstract] [Full Text] [Related]
